Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population
Year: 2026
Type: article
Abstract: We read with interest the report by Ternhamar and colleagues about lower dementia risk with earlier statin initiation after diagnosis of type 2 diabetes in statin-naïve individuals.1 The authors should be commended for addressing one of the fundamental issues of observational studies, the prevalent-user bias, with the use of a new-user design. We highlight a less apparent issue for clinicians: the transition from real patients to cloned synthetic patients.
Institutions: Georgetown University, George Washington University, Veterans Health Administration, Washington DC VA Medical Center, The Heart Research Institute, Saarland University, German Centre for Cardiovascular Research, Charité – Universitätsmedizin Berlin, University of Glasgow, University of California, Los Angeles
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $4,930
OpenAlex ID: W7228147266
